sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Cardiovascular Devices Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 66.25 Billion
Market Size 2025 · Base Year
US$ 128.45 Billion
Projected Market Size by 2033
8.63%
CAGR · 2026–2033
SHARE
BMIPUB00032568 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including Medtronic, Boston Scientific Corporation, Abbott, Biosense Webster, Inc. (Johnson and Johnson), General Electric Company
400
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Rising prevalence of heart diseases

  • Growth in minimally invasive procedures

  • Increasing aging population

Where Growth Opportunities Exist

Key Opportunities

  • Adoption in emerging markets

  • Development of AI-enabled devices

  • Expansion in home monitoring solutions

What Could Slow It Down

Market Restraints

  • High cost of advanced device

  • Stringent regulatory approval

  • Risk of device-related complications

Market Segmentation

Coverage by Segment

Device Type

Diagnostic and Monitoring Devices [Electrocardiogram (ECG)
Remote Cardiac Monitoring
Others]

Application

Coronary Artery Disease (CAD)
Cardiac Arrhythmia
Heart Failure

End User

Hospitals
Specialty Clinics
Others
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Medtronic
Boston Scientific Corporation
Abbott
Biosense Webster, Inc. (Johnson and Johnson)
General Electric Company
Koninklijke Philips N.V.
Siemens AG
BD
B. Braun Melsungen AG
Edwards Lifesciences Corporation
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 66.25 Billion
Market Size 2033 US$ 128.45 Billion
CAGR 2026–2033 8.63%
Segments By Device Type (Diagnostic and Monitoring Devices [Electrocardiogram (ECG), Remote Cardiac Monitoring, Others])  |  By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure)  |  By End User (Hospitals, Specialty Clinics, Others)
Geographies North America (US, Canada, Mexico)  ·  Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom)  ·  Asia-Pacific (Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan)  ·  South and Central America (Brazil, Argentina, Peru, Chile, Colombia)  ·  Middle East and Africa (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00032568
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 400 pages of in-depth Cardiovascular Devices Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.